Cladribine is linked to lower risk for disability progression in patients with relapsing-remitting multiple sclerosis vs ...

What are called autoimmune diseases can affect just about every part of the body — even the brain — and tens of millions of ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults with relapsing MS.

Thousands of Australians battling a debilitating form of multiple sclerosis have been granted a reprieve, as a groundbreaking ...

A dramatic price plunge has put a world-class therapy within reach, offering new freedom and hope for thousands of Australians.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio March is Multiple Sclerosis Awareness ...

There is no cure, meaning most people with MS are on lifelong treatment. From this week, a new treatment Ocrevus SC is ...

Many people living with MS are limited from taking nature walks shown to improve mental health, so Hala Darwish is bringing ...

Key opinion leaders highlight the MS treatment landscape. Ryan Haumschild, PharmD, MS, MBA: Now that we’ve talked about the background of multiple sclerosis [MS] in detail, I think it’s important for ...

CHICAGO (WLS) -- On Sunday, 2,500 friends, families and co-workers met at Walk MS: Chicago to raise awareness and funds to find a cure for multiple sclerosis. Hosted by the National Multiple Sclerosis ...

Initiating treatment for multiple sclerosis (MS) within 6 months of the first symptoms is associated with a significantly lower risk for severe disability one decade later, a new study suggests.